Stay updated with breaking news from Chiara Azzari. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Around 1 in 10 of us carry the most common cause of bacterial meningitis in our nose and throats. Here are the signs to look out for
First Patient Enrolled in KIDCARES10, Kedrion Biopharma Pediatric Primary Immunodeficiency Study - Objectives of KIDCARES10 Study (KIg10 in peDiatric subjects: effiCacy, sAfety and phaRmacokinEticS of a 10% IG) a phase III, open-label, prospective, multi-center study are to assess the efficacy, safety, and pharmacokinetics of a 10 percent intravenous immunoglobulin (IVIG) in pediatric patients aged 2 to 17 years and affected by primary immunodeficiency disease (PI) - Primary efficacy endpoint of KIDCARES10 is incidence rate of acute serious bacterial infections from day 1 to week 51/52 - Prim...